RxDoctor Payments Data

William Hardin

Nurse Practitioner · Baton Rouge, LANPI 1073508552

Payments from drug & device makers

$4,211in general payments, 2019–2025

Across 154 payments — averaging $27.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Harmony Biosciences LLC$1K
  • Jazz Pharmaceuticals Inc.$950
  • Inspire Medical Systems, Inc.$893
  • Axsome Therapeutics, Inc.$754
  • Idorsia Pharmaceuticals US Inc$126
  • Eisai Inc.$101
  • plus $216 from 4 others

What the payments were for

  • Food & beverage$4,11198%
  • Education$1002%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,211 in reported general payments places this provider in the 85th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Medicare billing

Part B allowed, 2024
$68,151
Medicare patients
542
Services billed
730

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxepin Hcl698$11,932
BelsomraSuvorexant18$7,674
Eszopiclone345$3,900
Quetiapine Fumarate349$3,239
Trazodone Hcl208$1,519
Zolpidem Tartrate230$1,183
Buspirone Hcl238$1,105
Clonazepam215$1,080
Modafinil28$816
Gabapentin119$693
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine14$550
Zolpidem Tartrate ErZolpidem Tartrate17$522
Temazepam59$401
Ropinirole Hcl20$398
Fluticasone Propionate26$344

Paid to pharmacies, not to this prescriber.

Other nurse practitioner in Baton Rouge

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →